BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Kidney
,
Neocentromeres
,
Valproic acid
,
rs7903146
,
PTEN
,
cell-cell adhesion
,
Influenza
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cefadroxil
Summary
General Info
Curated Studies
Most Correlated Studies
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
Cefadroxil Use for Musculoskeletal Infections in an Academic Pediatric Hospital.
Degradation of cefadroxil drug by newly designed solar light responsive alcoholic template-based lan…
Cefadroxil Comparable to Cephalexin: Minimum Inhibitory Concentrations among Methicillin-Susceptible…
Reanalysis of cefazolin surrogate susceptibility breakpoints utilized as guidances for oral cephalos…
A Critical Review of Cephalexin and Cefadroxil for the Treatment of Acute Uncomplicated Lower Urinar…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
To Assess the Effect of AZD1722 on the Pharmacokinetics of Cefadroxil in Healthy Volunteers
Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections
Cefadroxil 500 mg Capsules Under Fasting Conditions
A Bioequivalence Study of Cefadroxil Film Coated Tablets After A Single Oral Dose Administration to …
Cefadroxil 500 mg Capsules in Normal Healthy Non-Smoking Male and Female Subjects.
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ